Navigation Links
AcroMetrix Announces Launch of First Liquid MRSA Positive Control
Date:3/25/2008

BENICIA, Calif., March 25 /PRNewswire/ -- AcroMetrix, a leading provider of quality control products and services for clinical diagnostic laboratories, announced today the launch of the first standardized External Quality Control for Methicillin Resistant Staphylococcus aureas (MRSA) molecular testing. The OptiQual MRSA Positive Control may be used to independently monitor all phases of MRSA DNA testing to ensure consistent and accurate results.

A study published October 2007 in the Journal of the American Medical Association estimated that MRSA infections resulted in the death of 18,650 out of 94,360 infected patients in the United States in 2005 -- death rate higher than that of HIV/AIDS in the same year. Since then, many efforts have been highlighted to urge state and federal lawmakers to enact a bill requiring all incoming hospital patients be screened for MRSA upon being admitted.

The costs involved when MRSA spreads through a hospital are staggering. The VA Medical Center of Pittsburgh estimated in September 2007 that nearly $35,000 is spent per patient in treatment for MRSA. In addition, the website for the Center for Medicare and Medicaid services states that CMS is analyzing the need to adjust reimbursements for hospital-acquired infections such as MRSA.

"With the urgency currently associated with the MRSA screening, it is critical that hospitals are able to implement screening tests with the appropriate level of quality control," said Michael J. Eck, President and CEO of AcroMetrix. "Many critical and costly treatment decisions will be based on the results of these tests so it is important for patients that the tests are properly monitored during all phases of the testing procedure."

Each lab can help to maintain CLIA compliance for qualitative PCR tests such as those used to detect MRSA DNA by using the OptiQual MRSA Positive Control daily. These controls contain inactivated whole MRSA bacteria, providing a safer method of monitoring the entire PCR process, from extraction through amplification and detection. Convenient and ready to use, the OptiQual MRSA Positive Control is stored at refrigerated temperatures. This product is for Research Use Only. Not for use in diagnostic procedures.

OptiQual(R) is a registered trademark of AcroMetrix.

About AcroMetrix

AcroMetrix, with facilities in Benicia, California and Alkmaar, The Netherlands, provides a comprehensive line of molecular and serological diagnostic quality control products that assist laboratories in meeting current government regulations regarding quality. AcroMetrix maintains this leadership role by consistently developing innovative standards, external run controls, and validation kits for molecular and serological testing in blood screening and clinical diagnostic laboratories. All AcroMetrix procedures are developed and manufactured under cGMP, following applicable FDA and ISO/EC standards. For more information on AcroMetrix please visit the company web site at http://www.acrometrix.com.


'/>"/>
SOURCE AcroMetrix
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. AcroMetrix Announces Launch of PeliSpy Chagas Positive Control
2. Evalve Announces CE Mark Approval of the Worlds First Percutaneous Valve Repair System
3. Laerdal Medical Announces Strategic Relationship
4. Almost Family Announces Acquisition of Apex Home Health
5. Methodist Healthcare - Memphis Hospitals Announces the Extension of Tender Offers
6. MarketResearch.com Announces Distribution of Wireless Healthcare Research
7. MarketResearch.com Announces Distribution of CarbonFree Research
8. LCA-Vision Announces the Opening of its 75th LasikPlus(R) Vision Center in Tulsa, Oklahoma
9. MedCom Announces Card Activation Wins Significant Court Ruling
10. Tempo Participacoes S.A. Announces Increase of 16.8% in Net Revenue and of 46.3% in EBITDA for 2007
11. Select Medical Corporation Announces Results for Fourth Quarter and Year Ended December 31, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... marketing services, which specializes in thought leadership , media relations, social media, ... and services that will be powered through Act-On, an intuitive marketing automation platform. ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... once again hosted their Military Wedding Giveaway, with the winning couple announced on ... Farms with services generously donated from local vendors: A Matter of Taste, Ryan ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... Justice jointly issued a letter to withdraw previous guidance issued by ... gender identity. The guidance issued in May 2016 by the Obama Administration came ...
(Date:2/23/2017)... ... February 23, 2017 , ... The ... funding innovative lymphoma research and serving the lymphoma community through a comprehensive series ... La Gorce Country Club in Miami Beach to host its Swirl: Miami Wine ...
(Date:2/23/2017)... Chapel Hill, NC (PRWEB) , ... February 23, 2017 , ... ... the Platinum Sponsor for ACPA’s 74th Annual Meeting. KLS is a longtime supporter ... in 2017 as an exhibitor and Platinum Sponsor," said Dr. Bob Havlik, 2017 ACPA ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Feb. 24, 2017 Research and Markets ... Analysis & Trends - Industry Forecast to 2025" report to ... ... CAGR of around 23.8% over the next decade to reach approximately ... market estimates and forecasts for all the given segments on global ...
(Date:2/24/2017)... Research and Markets has announced the addition of the ... offering. ... Hemophilia Drugs Price Analysis and Strategies - 2016, provides drug pricing data ... following questions: What are the key drugs ... the Global Hemophilia market? What are the unit prices ...
(Date:2/24/2017)... -- In conjunction with DURECT Corporation,s (Nasdaq: DRRX ... are invited to listen to a conference call that ... March 14, 2017 at 4:30 pm Eastern Time (1:30 ... of the presentation will be available by accessing DURECT,s ... If you are unable to participate during the live ...
Breaking Medicine Technology: